Hojung Nam
Hojung Nam publishes mostly in Molecular Biology, Computational Theory and Mathematics and Cancer Research, on topics such as Computational Drug Discovery Methods, Bioinformatics and Genomic Networks and Microbial Metabolic Engineering and Bioproduction.
- World rank
- #529,534 of 7,710,434 ranked researchers
- Rank in South Korea
- #4,215 of 162,609
- Works
- 113
- Citations
- 4.6k
- Citations per work
- 40.7
What does Hojung Nam research?
Hojung Nam's work is mostly in Biochemistry, Genetics and Molecular Biology (49%), Computer Science (10%), Engineering (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences5549.0%
- Everything else3329.3%
- Physical Sciences2521.7%
- Computer Science1110.1%
- Engineering87.1%
- Materials Science54.5%
- 1Molecular Biology44% of their works
- 2Computational Theory and Mathematics10% of their works
- 3Cancer Research5% of their works
- 4Materials Chemistry4% of their works
- 5Electrical and Electronic Engineering4% of their works
- 6Biomedical Engineering3% of their works
Research topics
- Computational Drug Discovery Methods
- Bioinformatics and Genomic Networks
- Microbial Metabolic Engineering and Bioproduction
- Gene expression and cancer classification
- Machine Learning in Bioinformatics
- Metabolomics and Mass Spectrometry Studies
- Machine Learning in Materials Science
- Cancer Genomics and Diagnostics
Which keywords describe Hojung Nam's research?
The keywords of their largest research topics: Machine Learning, Molecular Docking, Virtual Screening, Gene Set Enrichment Analysis, Protein-Protein Interaction Networks, Bioinformatics, Data Analysis and Genome-Scale Models.
- Cancer Genomics
- Materials Informatics
- High-Throughput
- Protein
- Gene Expression
- Genome-Scale Models
- Bioinformatics
- Gene Set Enrichment Analysis
- Molecular Docking
- Machine Learning
- Virtual Screening
- Protein-Protein Interaction Networks
- Data Analysis
- Metabolic Engineering
- Microarray
- Subcellular Localization
- Mass Spectrometry
- Metabolomics
- Mutational Signatures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Machine Learning554 topics
- Molecular Docking271 topic
- Virtual Screening271 topic
- Gene Set Enrichment Analysis251 topic
- Protein-Protein Interaction Networks251 topic
- Bioinformatics202 topics
- Data Analysis182 topics
- Genome-Scale Models111 topic
- Metabolic Engineering111 topic
- Gene Expression101 topic
- Microarray101 topic
- Protein101 topic
- Subcellular Localization101 topic
- High-Throughput81 topic
- Mass Spectrometry81 topic
- Materials Informatics81 topic
- Metabolomics81 topic
- Cancer Genomics71 topic
- Mutational Signatures71 topic
Where does Hojung Nam work?
Hojung Nam's main affiliation in the publication record is Gwangju Institute of Science and Technology, South Korea.
How many publications and citations does Hojung Nam have?
OpenAlex counts 113 works and 4,603 citations for Hojung Nam, an h-index of 29, ranking #529,534 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hojung Nam. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.